-
Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
prnasia
April 28, 2021
Varian, a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden.
-
Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients
prnasia
December 16, 2020
Varian today announced that it has entered into a three-year agreement with Yonsei Cancer Center, Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology.
-
Varian inks bead agreement with Boston Scientific for cancer care
biospectrumasia
July 08, 2019
Varian,?a US based leader in developing and delivering cancer care solutions,? has announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating art
-
Varian to acquire Cancer Treatment Services International for $283M
biospectrumasia
May 21, 2019
This transaction will accelerate identification of unmet clinical and operational needs to facilitate advances in technology and services.
-
Varian partners with Proton Therapy
biospectrumasia
May 15, 2019
This installation marks a key milestone for the first proton therapy center in Singapore, ASEAN, Australia and New Zealand.
-
Varian,Tata Trust collaborate for advanced cancer care solutions
biospectrumasia
March 12, 2019
The Varian ARIA? oncology information system and Eclipse? treatment planning system will be implemented in a secure network hosted on a private cloud, to assist in elevating the level of care across India
-
Varian acquires HumediQ Global GMbH
biospectrumasia
August 08, 2018
This acquisition expands Varian's motion-management portfolio and is part of the company's long-term growth and value creation strategy.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
